Aktie A0ERVL REMEDENT, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Remedent, Inc.

Aktien

A0ERVL

US75954T1043

REMI

Markt geschlossen - OTC Markets
Andere Börsenplätze
 19:41:52 12.04.2024 		% 5 Tage % 1. Jan.
0,055 USD -15,84 % Intraday Chart für Remedent, Inc. -.--% -43,30 %
2023 Remedent, Inc. meldet Ergebnis für das am 31. März 2023 endende Geschäftsjahr CI
2022 Remedent, Inc. meldet Ergebnis für das am 31. März 2022 beendete Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022
Remedent : Attorney Letter - Lockett + Horwitz - Remedent, Inc. 2022-06-30 - re Annual Report
Remedent : Annual Report for Year Ended March 31, 2022
REMEDENT, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Remedent, Inc. Files Form 15 to Suspend SEC Exchange Act Registration and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet Companies
Remedent announces its agreement with Aurum Ceramic Dental Laboratories Co., concerning an Exclusive Master License Agreement in reference to its GlamSmile Veneers and Technology
Remedent Announces Agreement with Aurum Ceramic Dental Laboratories Co., Concerning an Exclusive Master License Agreement in Reference to Its Glamsmile Veneers and Technology
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2020
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2020
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2020
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
REMEDENT : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2019
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2019
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2019
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0ERVL Aktie
  4. Nachrichten Remedent, Inc.
  5. Andere Sprachen